Skip to content

Utility of CrocsRx Clog as a Diabetic House Shoe: a Pilot Study

Do CrocsRx Clogs Reduce Dynamic Plantar Pressure as Compared to Conventional House Shoes in Subjects With Diabetes?

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02228629
Enrollment
45
Registered
2014-08-29
Start date
2014-10-31
Completion date
2015-10-31
Last updated
2015-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes

Keywords

Diabetes, Foot complications, plantar keratoma, plantar pressure

Brief summary

Foot complications are a common and costly problem for subjects with diabetes. Although Medicare provides a pair of diabetic shoes yearly for subjects with diabetes, many do not wear their diabetic shoes in and around their house. Instead, subjects may wear shoes, such as flip flops or slippers, that provide little to no protection against injuries. While proper house shoe is important in the prevention of diabetic foot complications, this area has not received much attention. The purpose of this pilot study is to assess if CrocsRx Medical silver cloud clogs - a lightweight clog with protective toe box, cushioning soles, and easy to don and doff - offer reduced dynamic plantar pressure magnitude, as compared to conventional house shoes, for subjects with diabetes. A Repeated Measures ANOVA study design will be used to assess dynamic plantar pressure in 2 shod conditions for each subject with the order of shoes randomized.

Interventions

DEVICECrocsRx Medical Silver cloud clogs

Sponsors

Temple University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
21 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* Male or female between the ages of 21 and 75 (inclusive) * Documented type 1 or type 2 diabetes mellitus * Demonstrated abnormal foot biomechanics by the presence of intractable plantar keratoma (IPK) beneath metatarsal heads or hallux * Participants with and without signs of peripheral neuropathy (unable to perceive a 10 gram monofilament or vibration perception threshold (VPT \> 25 Volts) * Able to walk independently without the use of walking aids (cane, crutches, or walker) * Able to speak and understand English * Able to understand the information in the consent form and willing and able to sign the consent form

Exclusion criteria

* History of lower limb amputations (excluding toe amputations) * Presence of cutaneous ulceration in the lower extremity * History of or active Charcot neuroarthropathy of either foot * Severe peripheral vascular disease (i.e. ischemic rest pain, 2-block claudication, or gangrene) * End stage kidney disease requiring hemodialysis, stroke, or widespread malignant disease * Pregnant or nursing * Not willing or able to make the required follow-up visits * Insufficient (corrected) vision to complete the questionnaire * Unable to fit into available shoe sizes

Design outcomes

Primary

MeasureTime frameDescription
Comparison of peak pressure sub-metatarsal 2 and hallux in usual house shoes versus the CrocsRx clogsAt visit 1.In-shoe plantar pressures will be measured using novel pedar-X system on subjects with diabetes while walking in 2 shod conditions: (1) their usual house shoe and (2) the CrocsRx clogs.

Countries

United States

Contacts

Primary ContactJinsup Song
jsong@temple.edu215-625-5369

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026